UK 114542
Latest Information Update: 30 Jan 2007
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Cyclic GMP phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 06 Nov 1998 No-Development-Reported for Erectile dysfunction in USA (Unknown route)
- 04 Sep 1996 Investigation in Erectile dysfunction in USA (Unknown route)